CERS fundamentals
Cerus Corporation revenue breakdown overview
Cerus Corporation revenue for the last year amounted to 201.32 M USD, the most of which — 180.27 M USD — came from its highest performing source at the moment, Blood Safety, the year earlier bringing 156.37 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cerus Corporation 111.07 M USD, and the year before that — 93.23 M USD.
By source
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
50.00 M
100.00 M
150.00 M
200.00 M
Blood Safety
Immunotherapies
Currency: USD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Blood Safety
91.92 M
130.86 M
162.05 M
156.37 M
180.27 M
Immunotherapies
—
—
—
—
—
By country
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
50.00 M
100.00 M
150.00 M
200.00 M
United States
Europe, Middle East and Africa
France
North America
Other
Belgium
Kuwait
Spain and Portugal
Switzerland
Commonwealth of Independent States
Europe
Japan
Currency: USD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
United States
31.52 M
67.50 M
101.39 M
93.23 M
111.07 M
Europe, Middle East and Africa
31.10 M
39.24 M
36.97 M
36.52 M
36.63 M
France
19.40 M
20.89 M
19.33 M
18.49 M
19.69 M
North America
863.00 K
1.47 M
2.59 M
5.96 M
10.72 M
Other
2.11 M
1.77 M
1.77 M
2.17 M
2.15 M
Belgium
6.92 M
—
—
—
—
Kuwait
—
—
—
—
—
Spain and Portugal
—
—
—
—
—
Switzerland
—
—
—
—
—
Commonwealth of Independent States
—
—
—
—
—
Europe
—
—
—
—
—
Japan
—
—
—
—
—